Virax Biolabs Group Limited announced that it established a regional headquarters at Dubai Science Park, a member of TECOM Group PJSC. The office space is located in the heart of the global science-focused community that enables research, innovation and businesses in the health, energy, life sciences and environment sectors. The new headquarters will accommodate the company's expansion into the Middle East and improve global operations by attracting local partnerships and talents.

By entering the region, Virax Biolab Group aims to increase its distribution reach of high-quality in-vitro diagnostics, innovative products and proprietary T-Cell tests while creating logistical efficiencies. The new headquarters will create new jobs and drive investment and talent to the UAE in line with the Dubai Economic Agreement D33. The addition of a regional headquarters in Dubai Science Park aligns perfectly with mission to bring world-class testing solutions for viral threats to additional geographies, said James Foster, Virax's Chairman of the Board of Directors and Chief Executive Officer.

The new headquarters will strengthen the distribution network they have developed for ViraxClear and enable further development of innovative technology behind Virax Immune, while tapping into an esteemed science and business community established at Dubai Science Park. Dubai Science Park is a global ecosystem that serves the entire value chain of the science, health and pharma sectors. Home to global MNEs, SMEs and start-ups, the hub contributes to Dubai's knowledge and innovation economy and its status as a medical tourism destination.